Difference in Serum Endostatin Levels in Diabetic Patients with Critical Limb Ischemia Treated by Autologous Cell Therapy or Percutaneous Transluminal Angioplasty

The aim of this study was to compare the serum levels of the anti-angiogenic factor endostatin (S-endostatin) as a potential marker of vasculogenesis after autologous cell therapy (ACT) versus percutaneous transluminal angioplasty (PTA) in diabetic patients with critical limb ischemia (CLI). A total...

Descripción completa

Detalles Bibliográficos
Autores principales: Nemcova, Andrea, Jirkovska, Alexandra, Dubsky, Michal, Kolesar, Libor, Bem, Robert, Fejfarova, Vladimira, Pysna, Anna, Woskova, Veronika, Skibova, Jelena, Jude, Edward B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6168989/
https://www.ncbi.nlm.nih.gov/pubmed/29860903
http://dx.doi.org/10.1177/0963689718775628

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6168989/
https://www.ncbi.nlm.nih.gov/pubmed/29860903
http://dx.doi.org/10.1177/0963689718775628

Ejemplares similares